Pricing
  1. JP-listed companies
  2. J-Pharma Co.,Ltd.
  3. Cash flow

J-Pharma Co.,Ltd.【JP:520A】Cash flow

Market cap
P/E ratio
J-Pharma develops innovative small-molecule drugs targeting LAT1 transporters to treat cancer and autoimmune diseases with novel mechanisms of action.
SummaryFinancialsDividendsHistoryWorkforce
Income statementBalance sheetCash flowOther
2024/032025/03
Depreciation & amortization20
Cash from operations -1,411-1,695
Capital expenditures-2-0
Cash from investing -30-0
Cash from financing 9252,924
Free cash flow
Raw aggregated data